[ad_1]
The administration of President Joe Biden has decided that the Emergent Biosolutions plant in Baltimore, Maryland, which produces vaccines for the British-Swedish company AstraZeneca and the US company Johnson & Johnson, will be fully controlled by the latter.
In this way, the production of “Astra Zeneca” in these facilities will be stopped, reports the “New York Times”.
The new US authorities took that step after 15 million doses of Johnson & Johnson vaccine were discarded due to an error in mixing the components of the two manufacturers’ drugs.
The Biden administration is concerned that the incident could undermine public confidence in the two drugs, which runs counter to plans by the US government to speed up vaccinations in the country.
As the newspaper notes, the Johnson & Johnson vaccine, unlike AstraZeneca, is one-component, and the American company received approval from the U.S. Food and Drug Administration (FDA) in late February to use its vaccine, while the AstraZeneca vaccine “is not yet approved for use in the United States.
AstraZeneca is in talks with the US authorities to find a new site to produce its version of the vaccine. At the same time, a representative of the plant said that the production of the drug by the British-Swedish company will not stop until the company receives a modified version of the contract.
[ad_2]
